Breast Cancer Clinical Trials in Chapel Hill, North Carolina
30 recruitingChapel Hill, North Carolina
Showing 1–20 of 30 trials
Recruiting
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Breast Cancer
Endomagnetics Ltd.184 enrolled2 locationsNCT06610539
Recruiting
Phase 2
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
Breast CancerResidual Disease
UNC Lineberger Comprehensive Cancer Center78 enrolled1 locationNCT07069595
Recruiting
Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
NRG Oncology3,960 enrolled1209 locationsNCT05879926
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 2
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Breast Cancer
Dana-Farber Cancer Institute110 enrolled15 locationsNCT04468061
Recruiting
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Breast CancerOvarian CancerLung Cancer+2 more
Carevive Systems, Inc.25 enrolled7 locationsNCT05974150
Recruiting
Not Applicable
Dissemination of BREASTChoice AIM1-B
Breast CancerBreast Neoplasms
UNC Lineberger Comprehensive Cancer Center20 enrolled1 locationNCT07396766
Recruiting
Not Applicable
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
Breast CancerCancer
UNC Lineberger Comprehensive Cancer Center240 enrolled1 locationNCT06096623
Recruiting
Not Applicable
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
Breast Cancer
UNC Lineberger Comprehensive Cancer Center500 enrolled2 locationsNCT03769415
Recruiting
Not Applicable
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
Breast CancerBreast Cancer Metastatic
UNC Lineberger Comprehensive Cancer Center200 enrolled1 locationNCT07389967
Recruiting
A Novel Approach Utilizing Organ Specific Age Proteomics
Breast Cancer
UNC Lineberger Comprehensive Cancer Center60 enrolled1 locationNCT06789653
Recruiting
Not Applicable
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Breast CancerMetastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center50 enrolled1 locationNCT07313306
Recruiting
Not Applicable
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Breast CancerLymph Node Metastasis
UNC Lineberger Comprehensive Cancer Center100 enrolled1 locationNCT07025785
Recruiting
Phase 3
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Breast Cancer
Canadian Cancer Trials Group2,140 enrolled475 locationsNCT03488693
Recruiting
Phase 2
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Breast CancerKidney NeoplasmsLiver Neoplasms
UNC Lineberger Comprehensive Cancer Center40 enrolled1 locationNCT07225114
Recruiting
Phase 1Phase 2
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
Breast CancerBrain Metastases, Adult
Colette Shen41 enrolled7 locationsNCT04711824
Recruiting
Not Applicable
BREAST Choice Decision Tool R21 - AIM2
Breast Cancer
UNC Lineberger Comprehensive Cancer Center50 enrolled1 locationNCT06817226
Recruiting
Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Breast CancerHER2-positive Breast CancerInvasive Carcinoma of the Breast+2 more
Dana-Farber Cancer Institute375 enrolled32 locationsNCT04569747
Recruiting
Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Breast CancerMetastatic Breast CancerHER2-low Breast Cancer+1 more
Ana C Garrido-Castro, MD357 enrolled11 locationsNCT06533826
Recruiting
UNC Pleural Fluid Registry
Breast CancerLung CancerLung Infection+2 more
UNC Lineberger Comprehensive Cancer Center9,999 enrolled1 locationNCT05620329